ArticleCurrent oncology (Toronto, Ont.)2024
The Development and Testing of a Patient Decision Aid for Individuals with Homologous Recombinant Proficient Ovarian Cancer Who Are Considering Niraparib Maintenance Therapy.
Laura Hopkins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.